Genitourinary dysfunction in Parkinson's disease
Identifieur interne : 002102 ( Main/Merge ); précédent : 002101; suivant : 002103Genitourinary dysfunction in Parkinson's disease
Auteurs : Ryuji Sakakibara [Japon] ; Tomoyuki Uchiyama [Japon] ; Tomonori Yamanishi [Japon] ; Masahiko Kishi [Japon]Source :
- Movement Disorders [ 0885-3185 ] ; 2010-01-15.
English descriptors
- KwdEn :
- Basal Ganglia (physiopathology), Erectile Dysfunction (etiology), Erectile Dysfunction (pathology), Erectile Dysfunction (therapy), Female, Humans, Male, Neural Pathways (physiopathology), Parkinson Disease (complications), Parkinson's disease, Urinary Bladder Diseases (etiology), Urinary Bladder Diseases (pathology), Urinary Bladder Diseases (therapy), autonomic nervous system, bladder dysfunction, dopamine, sexual dysfunction.
- MESH :
- complications : Parkinson Disease.
- etiology : Erectile Dysfunction, Urinary Bladder Diseases.
- pathology : Erectile Dysfunction, Urinary Bladder Diseases.
- physiopathology : Basal Ganglia, Neural Pathways.
- therapy : Erectile Dysfunction, Urinary Bladder Diseases.
- Female, Humans, Male.
Abstract
Bladder dysfunction (urinary urgency/frequency) and sexual dysfunction (erectile dysfunction) are common nonmotor disorders in Parkinson's disease (PD). In contrast to motor disorders, genitourinary autonomic dysfunctions are often nonresponsive to levodopa treatment. The brain pathology causing the bladder dysfunction (appearance of overactivity) involves an altered dopamine‐basal ganglia circuit, which normally suppresses the micturition reflex. By contrast, hypothalamic dysfunction is mostly responsible for the sexual dysfunction (decrease in libido and erection) in PD, via altered dopamine‐oxytocin pathways, which normally promote libido and erection. The pathophysiology of the genitourinary dysfunction in PD differs from that in multiple system atrophy; therefore, it might aid in differential diagnosis. Anticholinergic agents are used to treat bladder dysfunction in PD, although these drugs should be used with caution particularly in elderly patients who have cognitive decline. Phosphodiesterase inhibitors are used to treat sexual dysfunction in PD. These treatments might be beneficial in maximizing the patients' quality of life. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.22519
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C48
- to stream Istex, to step Curation: 000C48
- to stream Istex, to step Checkpoint: 000945
- to stream PubMed, to step Corpus: 001A28
- to stream PubMed, to step Curation: 001A28
- to stream PubMed, to step Checkpoint: 001862
- to stream Ncbi, to step Merge: 002974
- to stream Ncbi, to step Curation: 002974
- to stream Ncbi, to step Checkpoint: 002974
Links to Exploration step
ISTEX:2522D61E7D3D87A8EA987AA52B3D96C2E1E2DA73Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Genitourinary dysfunction in Parkinson's disease</title>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
</author>
<author><name sortKey="Uchiyama, Tomoyuki" sort="Uchiyama, Tomoyuki" uniqKey="Uchiyama T" first="Tomoyuki" last="Uchiyama">Tomoyuki Uchiyama</name>
</author>
<author><name sortKey="Yamanishi, Tomonori" sort="Yamanishi, Tomonori" uniqKey="Yamanishi T" first="Tomonori" last="Yamanishi">Tomonori Yamanishi</name>
</author>
<author><name sortKey="Kishi, Masahiko" sort="Kishi, Masahiko" uniqKey="Kishi M" first="Masahiko" last="Kishi">Masahiko Kishi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2522D61E7D3D87A8EA987AA52B3D96C2E1E2DA73</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.22519</idno>
<idno type="url">https://api.istex.fr/document/2522D61E7D3D87A8EA987AA52B3D96C2E1E2DA73/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000C48</idno>
<idno type="wicri:Area/Istex/Curation">000C48</idno>
<idno type="wicri:Area/Istex/Checkpoint">000945</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Sakakibara R:genitourinary:dysfunction:in</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:20077468</idno>
<idno type="wicri:Area/PubMed/Corpus">001A28</idno>
<idno type="wicri:Area/PubMed/Curation">001A28</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001862</idno>
<idno type="wicri:Area/Ncbi/Merge">002974</idno>
<idno type="wicri:Area/Ncbi/Curation">002974</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002974</idno>
<idno type="wicri:Area/Main/Merge">002102</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Genitourinary dysfunction in Parkinson's disease</title>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University, Shimoshizu, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Chiba University, Chiba</wicri:regionArea>
<wicri:noRegion>Chiba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Uchiyama, Tomoyuki" sort="Uchiyama, Tomoyuki" uniqKey="Uchiyama T" first="Tomoyuki" last="Uchiyama">Tomoyuki Uchiyama</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Chiba University, Chiba</wicri:regionArea>
<wicri:noRegion>Chiba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yamanishi, Tomonori" sort="Yamanishi, Tomonori" uniqKey="Yamanishi T" first="Tomonori" last="Yamanishi">Tomonori Yamanishi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Urology, Dokkyo Medical College, Tochigi</wicri:regionArea>
<wicri:noRegion>Tochigi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kishi, Masahiko" sort="Kishi, Masahiko" uniqKey="Kishi M" first="Masahiko" last="Kishi">Masahiko Kishi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University, Shimoshizu, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-01-15">2010-01-15</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="2">2</biblScope>
<biblScope unit="page" to="12">12</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">2522D61E7D3D87A8EA987AA52B3D96C2E1E2DA73</idno>
<idno type="DOI">10.1002/mds.22519</idno>
<idno type="ArticleID">MDS22519</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Basal Ganglia (physiopathology)</term>
<term>Erectile Dysfunction (etiology)</term>
<term>Erectile Dysfunction (pathology)</term>
<term>Erectile Dysfunction (therapy)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Neural Pathways (physiopathology)</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson's disease</term>
<term>Urinary Bladder Diseases (etiology)</term>
<term>Urinary Bladder Diseases (pathology)</term>
<term>Urinary Bladder Diseases (therapy)</term>
<term>autonomic nervous system</term>
<term>bladder dysfunction</term>
<term>dopamine</term>
<term>sexual dysfunction</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Erectile Dysfunction</term>
<term>Urinary Bladder Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Erectile Dysfunction</term>
<term>Urinary Bladder Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Basal Ganglia</term>
<term>Neural Pathways</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Erectile Dysfunction</term>
<term>Urinary Bladder Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Male</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Bladder dysfunction (urinary urgency/frequency) and sexual dysfunction (erectile dysfunction) are common nonmotor disorders in Parkinson's disease (PD). In contrast to motor disorders, genitourinary autonomic dysfunctions are often nonresponsive to levodopa treatment. The brain pathology causing the bladder dysfunction (appearance of overactivity) involves an altered dopamine‐basal ganglia circuit, which normally suppresses the micturition reflex. By contrast, hypothalamic dysfunction is mostly responsible for the sexual dysfunction (decrease in libido and erection) in PD, via altered dopamine‐oxytocin pathways, which normally promote libido and erection. The pathophysiology of the genitourinary dysfunction in PD differs from that in multiple system atrophy; therefore, it might aid in differential diagnosis. Anticholinergic agents are used to treat bladder dysfunction in PD, although these drugs should be used with caution particularly in elderly patients who have cognitive decline. Phosphodiesterase inhibitors are used to treat sexual dysfunction in PD. These treatments might be beneficial in maximizing the patients' quality of life. © 2010 Movement Disorder Society</div>
</front>
</TEI>
<double doi="10.1002/mds.22519"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Genitourinary dysfunction in Parkinson's disease</title>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
</author>
<author><name sortKey="Uchiyama, Tomoyuki" sort="Uchiyama, Tomoyuki" uniqKey="Uchiyama T" first="Tomoyuki" last="Uchiyama">Tomoyuki Uchiyama</name>
</author>
<author><name sortKey="Yamanishi, Tomonori" sort="Yamanishi, Tomonori" uniqKey="Yamanishi T" first="Tomonori" last="Yamanishi">Tomonori Yamanishi</name>
</author>
<author><name sortKey="Kishi, Masahiko" sort="Kishi, Masahiko" uniqKey="Kishi M" first="Masahiko" last="Kishi">Masahiko Kishi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2522D61E7D3D87A8EA987AA52B3D96C2E1E2DA73</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.22519</idno>
<idno type="url">https://api.istex.fr/document/2522D61E7D3D87A8EA987AA52B3D96C2E1E2DA73/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000C48</idno>
<idno type="wicri:Area/Istex/Curation">000C48</idno>
<idno type="wicri:Area/Istex/Checkpoint">000945</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Sakakibara R:genitourinary:dysfunction:in</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Genitourinary dysfunction in Parkinson's disease</title>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University, Shimoshizu, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Chiba University, Chiba</wicri:regionArea>
<wicri:noRegion>Chiba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Uchiyama, Tomoyuki" sort="Uchiyama, Tomoyuki" uniqKey="Uchiyama T" first="Tomoyuki" last="Uchiyama">Tomoyuki Uchiyama</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Chiba University, Chiba</wicri:regionArea>
<wicri:noRegion>Chiba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yamanishi, Tomonori" sort="Yamanishi, Tomonori" uniqKey="Yamanishi T" first="Tomonori" last="Yamanishi">Tomonori Yamanishi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Urology, Dokkyo Medical College, Tochigi</wicri:regionArea>
<wicri:noRegion>Tochigi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kishi, Masahiko" sort="Kishi, Masahiko" uniqKey="Kishi M" first="Masahiko" last="Kishi">Masahiko Kishi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University, Shimoshizu, Sakura</wicri:regionArea>
<wicri:noRegion>Sakura</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-01-15">2010-01-15</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="2">2</biblScope>
<biblScope unit="page" to="12">12</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">2522D61E7D3D87A8EA987AA52B3D96C2E1E2DA73</idno>
<idno type="DOI">10.1002/mds.22519</idno>
<idno type="ArticleID">MDS22519</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term>
<term>autonomic nervous system</term>
<term>bladder dysfunction</term>
<term>dopamine</term>
<term>sexual dysfunction</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Bladder dysfunction (urinary urgency/frequency) and sexual dysfunction (erectile dysfunction) are common nonmotor disorders in Parkinson's disease (PD). In contrast to motor disorders, genitourinary autonomic dysfunctions are often nonresponsive to levodopa treatment. The brain pathology causing the bladder dysfunction (appearance of overactivity) involves an altered dopamine‐basal ganglia circuit, which normally suppresses the micturition reflex. By contrast, hypothalamic dysfunction is mostly responsible for the sexual dysfunction (decrease in libido and erection) in PD, via altered dopamine‐oxytocin pathways, which normally promote libido and erection. The pathophysiology of the genitourinary dysfunction in PD differs from that in multiple system atrophy; therefore, it might aid in differential diagnosis. Anticholinergic agents are used to treat bladder dysfunction in PD, although these drugs should be used with caution particularly in elderly patients who have cognitive decline. Phosphodiesterase inhibitors are used to treat sexual dysfunction in PD. These treatments might be beneficial in maximizing the patients' quality of life. © 2010 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Genitourinary dysfunction in Parkinson's disease.</title>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
<affiliation wicri:level="1"><nlm:affiliation>Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University, Shimoshizu, Sakura 285-8741, Japan. sakakibara@sakura.med.toho-u.ac.jp</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University, Shimoshizu, Sakura 285-8741</wicri:regionArea>
<wicri:noRegion>Sakura 285-8741</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Uchiyama, Tomoyuki" sort="Uchiyama, Tomoyuki" uniqKey="Uchiyama T" first="Tomoyuki" last="Uchiyama">Tomoyuki Uchiyama</name>
</author>
<author><name sortKey="Yamanishi, Tomonori" sort="Yamanishi, Tomonori" uniqKey="Yamanishi T" first="Tomonori" last="Yamanishi">Tomonori Yamanishi</name>
</author>
<author><name sortKey="Kishi, Masahiko" sort="Kishi, Masahiko" uniqKey="Kishi M" first="Masahiko" last="Kishi">Masahiko Kishi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1002/mds.22519</idno>
<idno type="RBID">pubmed:20077468</idno>
<idno type="pmid">20077468</idno>
<idno type="wicri:Area/PubMed/Corpus">001A28</idno>
<idno type="wicri:Area/PubMed/Curation">001A28</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001862</idno>
<idno type="wicri:Area/Ncbi/Merge">002974</idno>
<idno type="wicri:Area/Ncbi/Curation">002974</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002974</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Genitourinary dysfunction in Parkinson's disease.</title>
<author><name sortKey="Sakakibara, Ryuji" sort="Sakakibara, Ryuji" uniqKey="Sakakibara R" first="Ryuji" last="Sakakibara">Ryuji Sakakibara</name>
<affiliation wicri:level="1"><nlm:affiliation>Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University, Shimoshizu, Sakura 285-8741, Japan. sakakibara@sakura.med.toho-u.ac.jp</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Neurology Division, Department of Internal Medicine, Sakura Medical Center, Toho University, Shimoshizu, Sakura 285-8741</wicri:regionArea>
<wicri:noRegion>Sakura 285-8741</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Uchiyama, Tomoyuki" sort="Uchiyama, Tomoyuki" uniqKey="Uchiyama T" first="Tomoyuki" last="Uchiyama">Tomoyuki Uchiyama</name>
</author>
<author><name sortKey="Yamanishi, Tomonori" sort="Yamanishi, Tomonori" uniqKey="Yamanishi T" first="Tomonori" last="Yamanishi">Tomonori Yamanishi</name>
</author>
<author><name sortKey="Kishi, Masahiko" sort="Kishi, Masahiko" uniqKey="Kishi M" first="Masahiko" last="Kishi">Masahiko Kishi</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Basal Ganglia (physiopathology)</term>
<term>Erectile Dysfunction (etiology)</term>
<term>Erectile Dysfunction (pathology)</term>
<term>Erectile Dysfunction (therapy)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Neural Pathways (physiopathology)</term>
<term>Parkinson Disease (complications)</term>
<term>Urinary Bladder Diseases (etiology)</term>
<term>Urinary Bladder Diseases (pathology)</term>
<term>Urinary Bladder Diseases (therapy)</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Erectile Dysfunction</term>
<term>Urinary Bladder Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Erectile Dysfunction</term>
<term>Urinary Bladder Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Basal Ganglia</term>
<term>Neural Pathways</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Erectile Dysfunction</term>
<term>Urinary Bladder Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Male</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Bladder dysfunction (urinary urgency/frequency) and sexual dysfunction (erectile dysfunction) are common nonmotor disorders in Parkinson's disease (PD). In contrast to motor disorders, genitourinary autonomic dysfunctions are often nonresponsive to levodopa treatment. The brain pathology causing the bladder dysfunction (appearance of overactivity) involves an altered dopamine-basal ganglia circuit, which normally suppresses the micturition reflex. By contrast, hypothalamic dysfunction is mostly responsible for the sexual dysfunction (decrease in libido and erection) in PD, via altered dopamine-oxytocin pathways, which normally promote libido and erection. The pathophysiology of the genitourinary dysfunction in PD differs from that in multiple system atrophy; therefore, it might aid in differential diagnosis. Anticholinergic agents are used to treat bladder dysfunction in PD, although these drugs should be used with caution particularly in elderly patients who have cognitive decline. Phosphodiesterase inhibitors are used to treat sexual dysfunction in PD. These treatments might be beneficial in maximizing the patients' quality of life.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002102 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 002102 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:2522D61E7D3D87A8EA987AA52B3D96C2E1E2DA73 |texte= Genitourinary dysfunction in Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |